Pfizer | PFE - Stock



Pfizer reported $11.67B in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
AbbVie USD 4.53B 345M Mar/2025
Abbott USD 6.95B 315M Jun/2025
ALKERMES USD 191.92M 8.49M Jun/2025
Amgen USD 6.58B 146M Jun/2025
AstraZeneca USD 6.47B 583M Jun/2025
Bayer EUR 12.11B 576M Jun/2025
Biogen USD 2.27B 400K Jun/2025
Bristol-Myers Squibb USD 2.74B 71M Jun/2025
Drreddys Laboratories 75.6B 3.97B Jun/2025
Eli Lilly USD 11.01B 1.7B Jun/2025
Gilead Sciences USD 1.83B 66M Jun/2025
GlaxoSmithKline GBP 6.07B 72M Jun/2025
Glaxosmithkline 6.07B 403M Jun/2025
J&J USD 12.66B 215M Mar/2025
Medtronic USD 5.48B 134M Apr/2025
Merck USD 6.6B 405M Jun/2025
Neurocrine Biosciences USD 56.9M 2.2M Jun/2025
Novartis USD 6.31B 478M Jun/2025
Novartis USD 6.31B 584M Jun/2025
Pacira USD 148.16M 14.41M Jun/2025
Perrigo USD 1.22B 60.5M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
Prestige Brands USD 153.13M 5.42M Jun/2025
Regeneron Pharmaceuticals USD 3.21B 760.7M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Sanofi EUR 9.62B 12.23B Jun/2025
Sanofi 9.62B 187M Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025
Zoetis USD 2.44B 74M Jun/2025